Optimization of Heart Failure Treatment and Implementation of a Risk-based Patient Care Model.
Optimization of Treatment in Patients With a Diagnosis of Heart Failure and Realization of a Care Model Based on Risk Stratification
1 other identifier
observational
2,428
1 country
1
Brief Summary
Collection of data from patients with heart failure, both in the acute phase (data collection during hospital admission) and in the chronic phase (data collection during outpatient follow-up), optimization of the treatment of patients with heart failure, and implementation of a care model based on risk stratification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
February 20, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedMarch 16, 2026
March 1, 2026
6.5 years
February 20, 2026
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Heart failure free survival
Risk of adverse clinical events (mortality and morbidity) in the short to medium term.
Follow up at 3 months, 6 months and 12 months
Secondary Outcomes (4)
Improvement of 3C-HF prognostic score
Follow up at 3 months
3C-HF score for heart failure free survival
Follow up at 12 months
Implement a transitional care model
Up to baseline
Prevent episodes of heart failure worsening.
Up to baseline
Eligibility Criteria
Patients with diagnosis of heart failure.
You may qualify if:
- Patients consecutively referred to the Cardiovascular Department with a diagnosis of acute heart failure between January 1, 2017 and May 31, 2020 and between June 1, 2020 and June 30, 2023.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asst Papa Giovanni Xxiii - Dip. Di Cardiologia
Bergamo, 24127, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Antonello Gavazzi, MD
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2026
First Posted
March 16, 2026
Study Start
January 1, 2017
Primary Completion
June 30, 2023
Study Completion
June 30, 2024
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share